Reference
Zacherl M, et al. First clinical results for radioligand therapy using the alpha emitter 255Ac- 225-PSMA II&T in patients with end stage mCRPC. Journal of Nuclear Medicine 61 (Suppl. 1): (plus oral presentation) abstr. 592, 1 May 2020. Available from: URL: http://jnm.snmjournals.org/content/61/supplement_1/592.abstract?sid=34a057bf-547a-4f75-982f-b52920c2cfce [abstract]
Rights and permissions
About this article
Cite this article
225-actinium-PSMA. Reactions Weekly 1830, 13 (2020). https://doi.org/10.1007/s40278-020-85963-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-85963-8